Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XBIO

Xenetic Biosciences Inc

May 13 • 04:00PM ET

3.18

+0.16 5.14 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: TNXP SABS ARTL PALI BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.23	Insider Own	14.61%	Shs Outstand	2.29M	Perf Week	0.32%
Market Cap	7.29M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.96M	Perf Month	-2.45%
Enterprise Value	-0.59M	PEG	-	EPS next Q	-	Inst Own	10.22%	Short Float	0.37%	Perf Quarter	48.60%
Income	-2.23M	P/S	2.45	EPS this Y	-	Inst Trans	4.03%	Short Ratio	0.36	Perf Half Y	20.00%
Sales	2.98M	P/B	0.99	EPS next Y	-	ROA	-32.61%	Short Interest	0.01M	Perf YTD	46.54%
Book/sh	3.23	P/C	0.93	EPS next 5Y	-	ROE	-37.01%	52W High	13.93 -77.17%	Perf Year	3.92%
Cash/sh	3.44	P/FCF	-	EPS past 3/5Y	30.07% 37.89%	ROIC	-38.57%	52W Low	1.90 67.37%	Perf 3Y	-3.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.36% 46.78%	Gross Margin	-	Volatility	6.00% 5.85%	Perf 5Y	-79.75%
Dividend TTM	-	EV/Sales	-0.20	EPS Y/Y TTM	37.12%	Oper. Margin	-95.23%	ATR (14)	0.20	Perf 10Y	-99.67%
Dividend Ex-Date	-	Quick Ratio	7.93	Sales Y/Y TTM	23.52%	Profit Margin	-75.06%	RSI (14)	54.42	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.93	EPS Q/Q	63.03%	SMA20	1.19%	Beta	2.21	Target Price	40.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	18.11%	SMA50	6.09%	Rel Volume	0.80	Prev Close	3.02
Employees	2	LT Debt/Eq	0.00	Earnings	Nov 13 BMO	SMA200	8.45%	Avg Volume	20.18K	Price	3.18
IPO	Jun 19, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	32.65% 63.02%	Trades		Volume	16,129	Change	5.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)